SRT1720 has been studied as a direct SIRT1 activator in microcirculation, ameliorating obesity-induced ED by promoting antioxidant protein expression while downregulating mitochondrial-aging proteins [10]. Here, SIRT1 is linked to obesity due to melanocortin 4 receptor deficiency.